Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Biolase Inc (BIOL)

1.24 -0.06 (-4.62%)

05-23 16:00

Open:

1.3

Pre. Close:

1.3

High:

1.653

Low:

1.19

Volume:

378,305

Market Cap:

25M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.655 - 1.664

1.664 - 1.671

Low:

1.169 - 1.179

1.179 - 1.186

Close:

1.225 - 1.24

1.24 - 1.252

Technical analysis  (as of: 2018-05-23 4:25:25 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 2.66     One year: 3.48

Support:

Support1: 1.14    Support2: 0.95

Resistance:

Resistance1: 2.28    Resistance2: 2.98

Pivot:

1.44

Moving Averages:

MA(5): 1.24     MA(20): 1.53

MA(100): 2.02     MA(250): 2.92

MACD:

MACD(12,26): -0.16     Signal(12,26,9): -0.14

%K %D:

%K(14,3): 5.25     %D(3): 4.42

RSI:

RSI(14): 31.86

52-Week:

High: 6  Low: 1.14  Change(%): -79.0

Average Vol(K):

3-Month: 5380  10-Days 19569

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
BIOL has closed above bottom band by 20.6%. Bollinger Bands are 22.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-05-10T06:00:00-04:00
Biolase Announces 1-for-5 Reverse Stock Split Common Stock Will Begin Trading On Split-Adjusted Basis On May 11

2018-05-09T08:00:00-04:00
BIOLASE and Los Angeles Chargers Partner to Bring Advanced Dental Care to Children in Underserved Communities in Southern California

2018-05-02T18:44:02-04:00
Biolase's (BIOL) CEO John Beaver on Q1 2018 Results - Earnings Call Transcript

2018-05-02T16:29:35-04:00
Biolase beats by $0.01, misses on revenue

2018-05-02T16:05:00-04:00
BIOLASE Reports 2018 First Quarter Results

2018-04-25T08:30:00-04:00
BIOLASE® To Host 2018 First Quarter Financial Results Conference Call On May 2, 2018

2018-04-17T08:00:00-04:00
BIOLASE Establishes Southern California Dental Advisory Board

2018-04-11T08:00:00-04:00
BIOLASE Board Of Directors Asks Chairman Jonathan T. Lord, M.D. To Take On Expanded Leadership Role And Explore Strategic Options

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Advanced Medical Equipment Technology

Shares Out. (M)

102.38

Shares Float (M)

99.08

% Held by Insiders

3.20

% Held by Institutions

36.10

Shares Short (K)

1772

Shares Short Prior Month (K)

1850

Stock Financials

EPS

EPS Est. Current Year

-0.160

EPS Est. Next Year

-0.100

EPS Est. Next Quarter

-0.030

Forward EPS

-0.070

Book Value (p.s.)

1.300

PEG Ratio

-0.13

Profit Margin

-38.64

Operating Margin

-37.36

Return on Assets (ttm)

-56.2

Return on Equity (ttm)

-100.4

Qtrly Rev. Growth

-8.2

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-18.41

Levered Free Cash Flow (M)

-12.12

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

0.95

P/S

39680000.00

P/CF

-6.90

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

2005-06-24

Forward Dividend

Last Split Date

2018-05-11

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.